1360-0443/asset/ADD_left.gif?v=1&s=ff0c3f03c55af35c71eb76c4e20692f85ff5ddce)
1360-0443/asset/ADD_right.gif?v=1&s=7ca96481359150dd1456363515089ad9eb936805)
Corrigendum
You have free access to this content
Corrigendum
Article first published online: 2 AUG 2012
DOI: 10.1111/j.1360-0443.2012.04033.x
© 2012 Society for the Study of Addiction
Additional Information
How to Cite
(2012), Corrigendum. Addiction, 107: 1718. doi: 10.1111/j.1360-0443.2012.04033.x
Publication History
- Issue published online: 2 AUG 2012
- Article first published online: 2 AUG 2012
- Abstract
- Article
- References
- Cited By
Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial
Ahmed Elkashef, Roberta Kahn, Elmer Yu, Erin Iturriaga, Shou-Hua Li, Ann Anderson, Nora Chiang, Nassima Ait-Daoud, David Weiss, Frances McSherry, Tracey Serpi, Richard Rawson, Mark Hrymoc, Dennis Weis, Michael McCann, Tony Pham, Christopher Stock, Ruth Dickinson, Jan Campbell, Charles Gorodetzky, William Haning, Barry Carlton, Joseph Mawhinney, Ming D. Li & Bankole A. Johnson
In the Design section of the Abstract [1], the dosage of 50 mg/day was incorrect, and should have read 25 mg/day.
Reference
- 1, , , , , et al. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction 2012 107: 1297–1306.